Skip to Content
ProceedingsProceedings
  • Abstract
  • Open Access

21 November 2023

Antioxidative and Anti-Borrelia Effects of Plantago Species †

,
,
,
and
1
Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia Tee 15, 12618 Tallinn, Estonia
2
HAN BioCentre, Laan van Scheut 2, 6525 EM Nijmegen, The Netherlands
3
National Institute for Health Development, Hiiu 42, 11619 Tallinn, Estonia
*
Author to whom correspondence should be addressed.
Borrelia burgdorferi sensu lato bacteria are the causative agent of Lyme disease, Europe’s most common vector-borne disease. In Estonia, the number of ticks carrying pathogenic bacteria and the case numbers of the illness are rapidly rising [1]. The infection can affect multiple organ systems and withstand several rounds of antibiotic treatment [2]. Therefore, novel treatment options are needed to combat the persister forms of the bacteria responsible for the chronic illness [3]. The screening of natural resources has shown promise in helping discover lead compounds with distinct anti-Borrelia activity for future therapeutic approaches. The antioxidative and antibacterial properties of several plants found in Estonia have been demonstrated by our group. This presentation discusses the chemical characterisation and anti-Borrelia activity determination of Plantago major and Plantago lanceolata. The plants’ main groups of bioactive compounds were quantified by colorimetric tests, total polyphenols by the Folin–Ciocalteu, total flavonoids by the AlCl3, and total iridoids by the Trim–Hill method. The results show that dried aerial parts of P. major and P. lanceolata contain up to 32.7 and 47.1 mg/g gallic acid equivalents of phenolic compounds, up to 10.0 and 14.4 mg/g quercetin equivalents of flavonoids, and up to 11.4 and 23.4 mg/g asperuloside equivalents of iridoids, respectively. The extracts were chemically characterised using HPLC–DAD–MS/MS. The antioxidative activity of all extracts was evaluated using the ORACFL method, and found to be up to 12.3 or 14.6 mg/g Trolox equivalents for P. major and P. lanceolata, respectively. The anti-Borrelia activity of the plant extracts was tested on the latent bacterial forms using the SYBR Green I and Propidium Iodide assay. The residual viability of B. burgdorferi bacteria after incubation with the plant extracts was as low as 18.7% for P. major species, and 23.6% for P. lanceolata species. Therefore, as our results demonstrate that both P. major and P. lanceolata contain considerable amounts of phytochemicals with antioxidant properties and show significant anti-Borrelia effects on the latent forms of B. burgdorferi, these plants should be considered for further therapeutic research.

Author Contributions

Conceptualization: M.V.; methodology: P.S.-R. and M.V.; formal analysis: R.D., P.-R.L., P.S.-R. and O.B.; investigation: P.-R.L., P.S.-R. and M.V.; data curation: P.-R.L. and P.S.-R.; writing—original draft preparation: P.-R.L.; writing—review and editing: P.-R.L. and M.V.; visualization: P.-R.L.; supervision: P.S.-R. and M.V.; project administration: M.V.; funding acquisition: M.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Estonian Center of Analytical Chemistry (ECAC) funded by the Estonian Research Council (TT4) and the R&D project SS220044 “Evaluation of antioxidant and antibacterial activity of plant extracts” funded by Tallinn University of Technology.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Geller, J.; Vikentjeva, M.; Bragina, O.; Jakovleva, J. Report: “Send Tick by Post!” Campaign of 2020 and Pathogens in Estonian Ticks. Available online: https://www.tai.ee/sites/default/files/2022-07/Puugiraport_2022.pdf (accessed on 26 June 2023).
  2. Singh, S.K.; Girschick, H.J. Lyme borreliosis: From infection to autoimmunity. Clin. Microbiol. Infect. 2004, 10, 598–614. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Sharma, B.; Brown, A.V.; Matluck, N.E.; Hu, L.T.; Lewis, K. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Antimicrob. Agents Chemother. 2015, 59, 4616–4624. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.